CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)

被引：37

作者：

Najjar, Sonia M. ^{[1
,2
]}

Russo, Lucia ^{[1
,2
]}

机构：

[1] Univ Toledo, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA

[2] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Toledo, OH 43614 USA

来源：

SEMINARS IN IMMUNOPATHOLOGY | 2014年 / 36卷 / 01期

关键词：

CEACAM1; Insulin resistance; Adipokines; Metabolic syndrome; NASH; FATTY-LIVER-DISEASE; TUMOR-NECROSIS-FACTOR; CELL-ADHESION MOLECULE-1; KILLER T-CELLS; INDUCED OXIDATIVE STRESS; ENDOPLASMIC-RETICULUM STRESS; COLONY-STIMULATING FACTOR; INDUCED HEPATIC STEATOSIS; RECEPTOR TYROSINE KINASE; KAPPA-B ACTIVATION;

D O I：

10.1007/s00281-013-0407-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Mounting epidemiological evidence points to an association between metabolic syndrome and non-alcoholic steatohepatitis (NASH), an increasingly recognized new epidemic. NASH pathologies include hepatocellular ballooning, lobular inflammation, hepatocellular injury, apoptosis, and hepatic fibrosis. We will review the relationship between insulin resistance and inflammation in visceral obesity and NASH in an attempt to shed more light on the pathogenesis of these major metabolic diseases. Moreover, we will identify loss of the carcinoembryonic antigen-related cell adhesion molecule 1 as a unifying mechanism linking the immunological and metabolic abnormalities in NASH.

引用

页码：55 / 71

页数：17

共 50 条

[31] Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice [J].

Hartmann, Phillipp ;

Duan, Yi ;

Miyamoto, Yukiko ;

Demir, Munevver ;

Lang, Sonja ;

Hasa, Elda ;

Stern, Patrick ;

Yamashita, Dennis ;

Conrad, Mary ;

Eckmann, Lars ;

Schnabl, Bernd .

HEPATOLOGY INTERNATIONAL, 2022, 16 (02) :359-370

[32] Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies [J].

Luci, Carmelo ;

Bourinet, Manon ;

Leclere, Pierre S. ;

Anty, Rodolphe ;

Gual, Philippe .

FRONTIERS IN ENDOCRINOLOGY, 2020, 11

[33] Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) [J].

Burra, Patrizia ;

Bizzaro, Debora ;

Gonta, Anna ;

Shalaby, Sarah ;

Gambato, Martina ;

Morelli, Maria Cristina ;

Trapani, Silvia ;

Floreani, Annarosa ;

Marra, Fabio ;

Brunetto, Maurizia Rossana ;

Taliani, Gloria ;

Villa, Erica .

LIVER INTERNATIONAL, 2021, 41 (08) :1713-1733

[34] Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients [J].

Sumida, Yoshio ;

Yonei, Yoshikazu ;

Kanemasa, Kazuyuki ;

Hara, Tasuku ;

Inada, Yutaka ;

Sakai, Kyoko ;

Imai, Shunsuke ;

Hibino, Sawako ;

Yamaguchi, Kanji ;

Mitsuyoshi, Hironori ;

Yasui, Kohichiroh ;

Minami, Masahito ;

Itoh, Yoshito ;

Naito, Yuji ;

Yoshikawa, Toshikazu ;

Okanoue, Takeshi .

HEPATOLOGY RESEARCH, 2010, 40 (09) :901-910

[35] Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future [J].

dos Santos, Joao Paulo Margiotti ;

de Maio, Mariana Canevari ;

Lemes, Monike Alves ;

Laurindo, Lucas Fornari ;

Haber, Jesselina Francisco dos Santos ;

Bechara, Marcelo Dib ;

do Prado, Pedro Sidnei ;

Rauen, Eduardo Costa ;

Costa, Fernando ;

Pereira, Barbara Cristina de Abreu ;

Flato, Uri Adrian Prync ;

Goulart, Ricardo de Alvares ;

Chagas, Eduardo Federighi Baisi ;

Barbalho, Sandra Maria .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)

[36] State of the art on the pathophysiology, diagnosis and treatment of non-alcoholic steatohepatitis (NASH) [J].

Grzych, G. ;

Bernard, L. ;

Lestrelin, R. ;

Tailleux, A. ;

Staels, B. .

ANNALES PHARMACEUTIQUES FRANCAISES, 2023, 81 (02) :183-201

[37] The future R&D landscape in non-alcoholic steatohepatitis (NASH) [J].

Black, Darcey ;

Brockbank, Sarah ;

Cruwys, Simon ;

Goldenstein, Kim ;

Hein, Peter ;

Humphries, Bob .

DRUG DISCOVERY TODAY, 2019, 24 (02) :560-566

[38] Oyster extracts attenuate pathological changes in non-alcoholic steatohepatitis (NASH) mouse model [J].

Watanabe, Mitsugu ;

Fuda, Hirotoshi ;

Okabe, Hiroaki ;

Joko, Sae ;

Miura, Yusuke ;

Hui, Shu-Ping ;

Yimin ;

Hamaoka, Naohiro ;

Miki, Emiko ;

Chiba, Hitoshi .

JOURNAL OF FUNCTIONAL FOODS, 2016, 20 :516-531

[39] Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms [J].

Lequoy, Marie ;

Gigante, Elia ;

Couty, Jean-Pierre ;

Desbois-Mouthon, Christele .

HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2020, 41 (01)

[40] Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis [J].

Piro, S. ;

Spadaro, L. ;

Russello, M. ;

Spampinato, D. ;

Oliveri, C. E. ;

Vasquez, E. ;

Benigno, R. ;

Brancato, F. ;

Purrello, F. ;

Rabuazzo, A. M. .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (08) :545-552

← 1 2 3 4 5 →